Logo
x

Search category

Subscribe Now

Japan

Daiichi Sankyo and Kite’s Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy Receives MHRA’s Approval for the Treatment of Lymphoma in Japan

Daiichi Sankyo and Kite’s Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy Receives MHRA’s Approval for the Treatment of Lymp...

  • December 17, 2021
Daiichi Sankyo and Kite’s Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy Receives MHRA’s Approval for the Treatment of Lymphoma in Japan

Daiichi Sankyo and Kite’s Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy Receives MHRA’s Approval for the Treatment of Lymp...

  • December 17, 2021
AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus

AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus

  • September 28, 2021
AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus

AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus

  • September 28, 2021
Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildly Active Luminal CD

Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildl...

  • September 27, 2021
Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildly Active Luminal CD

Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildl...

  • September 27, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.